ANENT EMPIRICAL ANTIBIOTIC THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS
Abstract
The authors have examined 370 patients with community-acquired pneumonia, mainly caused by pneumococcus, clamydia and mycoplasma. Klebsiella рneumoniae as a marker indicating prognostically unfavourable course of the disease was detected concurrent to associated severe diseases. Initial antibiotic treatment should be chosen with due regard given to regional etiological disease profile. In authors' opinion, Levofloxacin is the most adequate drug intended for treating the communityacquired pneumonia
About the Authors
О. Молчанова
Институт повышения квалификации специалистов здравоохранения;
Краевая клиническая больница № 1 им. С.И. Сергеева
Russian Federation
Russian Federation
А. Островский
Институт повышения квалификации специалистов здравоохранения;
Краевая клиническая больница № 1 им. С.И. Сергеева
Russian Federation
Russian Federation
Э. Щенников
Институт повышения квалификации специалистов здравоохранения
Russian Federation
Russian Federation
А. Хамидулина
Институт повышения квалификации специалистов здравоохранения
Russian Federation
Russian Federation
O. V. Molchanova
Institute of Advanced Training for Health Care Specialists;
Regional Clinical Hospital No.1 named after S.I. Sergeev
Russian Federation
Russian Federation
A. B. Ostrovskiy
Institute of Advanced Training for Health Care Specialists;
Regional Clinical Hospital No.1 named after S.I. Sergeev
Russian Federation
Russian Federation
E. L. Schennikov
Institute of Advanced Training for Health Care Specialists
Russian Federation
Russian Federation
A. I. Khamidulina
Institute of Advanced Training for Health Care Specialists
Russian Federation
Russian Federation
References
1. Внебольничная пневмония у взрослых / Чучалин А.Г., Синопальников А.И., Страчунский Л.С. и др. М.: М-Вести, 2006. 76 с.
2. Гублер Е.В. Вычислительные методы анализа и распознавания патологических процессов. - Л.: Медицина, 1978.
3. Страчунский Л.С., Дехтич А.В. Современные клинические рекомендации по антимикробной терапии. Смоленск: Макмах, 2004. 384 с.
4. Страчунский Л.С., Козлов Р.С. Современные методы клинической микробиологии. Смоленск: Макмах, 2003. 104 с.
5. Чучалин А.Г., Синопальников А.И. Внебольничная пневмония у взрослых. М.: Атмосфера, 2005. 200 с.
6. Almirall J., Boixeda R., Bolibar I. et al. Differences in the etiology of community-acquired pneumonia according to site of care: a population-based study // Respir. Med. 2007. No. 11. P. 1909-1915.
7. Fernandez M., Zagolin M., Ruiz M. et al. Community acquired pneumonia in a hospitalized community: etiological study // Rev. Med. Chil. 2003. No. 5. Р. 498-504.
8. Ishida T., Hashimoto T., Arita M. et al. A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology // Chest. 2001. No. 4. Р. 1295-1296.
9. Lauderdale T.L., Chang F.Y., Ben P.J. et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan // Respir. Medical. 2005. No. 9. Р. 1079-1086.
Review
For citations:
, , , , Molchanova O.V., Ostrovskiy A.B., Schennikov E.L., Khamidulina A.I. ANENT EMPIRICAL ANTIBIOTIC THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS. Pacific Medical Journal. 2010;(1):58-59. (In Russ.)
Views:
255
Email this article 